LNC
NVO

Lincoln National Corp’s Novo Nordisk NVO Stock Holding History

Lincoln National Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,128
Closed -$3.35M – 780
2024
Q1 		$3.35M Buy
26,128
+2,394
+10% +$285K 0.05% 223
2023
Q4 		$2.46M Buy
23,734
+5,478
+30% +$542K 0.04% 249
2023
Q3 		$1.66M Buy
18,256
+946
+5% +$83.3K 0.03% 293
2023
Q2 		$1.4M Buy
17,310
+1,296
+8% +$106K 0.03% 328
2023
Q1 		$1.27M Buy
16,014
+684
+4% +$48.5K 0.03% 333
2022
Q4 		$1.04M Buy
15,330
+2,068
+16% +$121K 0.02% 351
2022
Q3 		$661K Buy
13,262
+1,074
+9% +$57.5K 0.02% 421
2022
Q2 		$679K Buy
12,188
+1,840
+18% +$102K 0.02% 415
2022
Q1 		$574K Buy
10,348
+380
+4% +$19.5K 0.01% 480
2021
Q4 		$558K Buy
9,968
+5,652
+131% +$306K 0.01% 486
2021
Q3 		$207K Sell
4,316
-590
-12% -$28.5K ﹤0.01% 812
2021
Q2 		$205K Sell
4,906
-6,020
-55% -$233K ﹤0.01% 807
2021
Q1 		$369K Buy
+10,926
New +$389K 0.01% 543
2018
Q1 		– Sell
-8,402
Closed -$225K – 576
2017
Q4 		$225K Buy
+8,402
New +$214K 0.01% 574

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lincoln National Corp's NVO Position: Q2 2024 in Review

Lincoln National Corp sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 26,128 shares — an estimated $3.35M sold.

Lincoln National Corp first reported a position in NVO in Q4 2017 and held it in 14 quarters. The position peaked at $3.35M in Q1 2024. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Lincoln National Corp reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 26,128 Novo Nordisk shares in Q2 2024, an estimated $3.35M.
  • Lincoln National Corp first reported a position in Novo Nordisk in Q4 2017 and held it in 14 quarters.
  • Lincoln National Corp's Novo Nordisk position peaked at $3.35M in Q1 2024.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.